Clinical Integration and Associate Doctor Employment Agreements in Veterinary and Dental M&A

Associate Doctor Employment Landscape: W-2 vs. 1099 Classification and the 2024 DOL Rule

The foundational classification question in any veterinary or dental associate relationship is whether the clinician is properly classified as an employee or as an independent contractor. The distinction determines who bears payroll tax obligations, whether workers compensation and unemployment insurance apply, whether benefit plan participation is available, and whether federal and state wage and hour protections cover the individual. Misclassification exposure is not theoretical in this industry: the Department of Labor, IRS, and state agencies have each conducted enforcement initiatives in the healthcare services sector that identified high rates of improper 1099 classification for clinical staff in corporate-affiliated practices.

The DOL's 2024 final rule on employee or independent contractor classification under the Fair Labor Standards Act reinstated a multi-factor economic reality test that examines the totality of the relationship rather than applying any single determinative criterion. The six core factors are: the opportunity for profit or loss depending on managerial skill, investment by the worker relative to the employer, the degree of permanence of the work relationship, the nature and degree of employer control, whether the work is integral to the employer's business, and the skill and initiative required. For a veterinarian or dentist working full-time at a single corporate-affiliated practice with set schedules, standardized protocols, and equipment provided by the employer, the economic reality test strongly supports employee classification. A contractor designation for such a clinician carries back-tax liability for both the employer and the worker, plus potential ERISA exposure if the misclassified worker should have been entitled to plan participation.

Dental hygienists and veterinary technicians occupy a distinct classification zone that the 2024 DOL rule affects differently than it affects licensed doctors. These mid-level clinical staff frequently work for multiple practices on a per-diem or part-time basis and have historically been classified as 1099 contractors by practices that use them flexibly. The economic reality test may support contractor status for hygienists and technicians who work genuinely independently, set their own schedules, serve multiple employers, and supply some of their own equipment. However, hygienists and technicians who work exclusively at one practice, under the direct supervision of an employed dentist or veterinarian, on a regular schedule, with employer-provided instruments and PPE, are more likely to be employees under the reinstated test. An acquiring DSO or veterinary group should audit the classification of all clinical staff in the target practice before closing and determine whether reclassification is required, because assuming a practice with a material misclassification exposure creates liability that accrues from the original misclassification date rather than from the acquisition date.

State classification laws often impose standards more protective of worker status than the federal FLSA test. California's ABC test, adopted through AB5 and applicable to certain industries, requires a hiring entity to establish that the worker is free from the control and direction of the hiring entity in connection with the performance of the work, that the worker performs work outside the usual course of the hiring entity's business, and that the worker is customarily engaged in an independently established trade, occupation, or business. Healthcare providers have pursued exemptions from AB5 with mixed success, and the application of the ABC test to veterinary associates and dental associates in California is unsettled enough that counsel should not assume the professional services exemption will protect a corporate group from scrutiny.

Production-Based Compensation: Net Production vs. Collections, Adjustments, Refunds, and Patient Defaults

Production-based compensation is the dominant model for associate doctor pay in veterinary and dental practices, and the specific mechanics of how production is calculated and adjusted determine the associate's effective earnings more than the stated commission percentage. Practices use three primary compensation bases: gross production, which is the full fee schedule value of services rendered; net production, which deducts contractual adjustments including insurance discounts and fee schedule write-downs before calculating the commission base; and collections, which calculates the commission on amounts actually received from patients and payers after all deductions including refunds and write-offs.

The difference between net production and collections can be material at a practice with a high managed care payer mix. If a dental practice has fee schedule reductions averaging 30 percent from its standard fees under its PPO contracts, an associate paid on 30 percent of net production receives 30 percent of 70 percent of the fee schedule value, while an associate paid on 30 percent of gross production receives 30 percent of 100 percent. The collections model creates an additional variable: the efficiency of the practice's revenue cycle management. An associate who delivers clinical work competently cannot control whether the front desk staff properly submits claims, whether appeals of denied claims are pursued, or whether patient balances are collected. Tying associate compensation to collections efficiency measures that the associate does not control is a structural inequity that affects retention.

Adjustments for patient refunds and patient defaults require specific definition in the employment agreement to prevent disputes. A refund issued because the practice overcollected on a patient's co-pay, or because a claim was reprocessed and the practice received a duplicate payment, is properly chargeable against the commission calculation for that service. A refund issued as a goodwill gesture for a service the associate performed competently is more contentious, and the employment agreement should specify whether goodwill refunds reduce the commission base and whether the associate has any input into the decision to issue such a refund. Patient defaults, meaning balances that are written off as uncollectable after collection efforts fail, are generally not chargeable against the associate in a net production model but are the defining disadvantage of a collections model from the associate's perspective.

Lab and dental supply chargebacks are an additional compensation mechanic used by some DSOs that reduces the associate's net production or collections base by the cost of laboratory work and materials ordered for the patient's treatment. The justification offered is that the associate controls the treatment plan and therefore controls the lab cost, and that a chargeback aligns the associate's incentives with cost efficiency. The practical effect is to reduce the associate's compensation for treatment plans that involve significant lab work, including implant cases, complex prosthetics, and specialty referrals that generate the highest production. An associate who reviews the employment agreement carefully will identify chargebacks as a potentially significant compensation reduction mechanism, particularly if the agreement does not cap the chargeback percentage or establish a dispute process for challenging chargeback calculations.

Guaranteed Draw vs. Pure Production, Associate Retention During Transition, and Stay Bonuses

The structure of base compensation during and after a practice acquisition is a retention tool as well as a legal obligation. Associates who are performing under a guaranteed draw against future production commissions have a known income floor that provides stability during the uncertainty of an ownership transition. Associates paid on pure production with no guaranteed minimum face the risk that transition-period disruptions, including staff changes, scheduling gaps, and credentialing delays, will reduce their production and therefore their income at the moment when they most need stability to make a decision about whether to remain with the practice under new ownership.

A guaranteed draw is a minimum payment that the employer commits to making regardless of production, with the understanding that the draw will be recouped from future commissions if production exceeds the draw level. The legal structure of draw recoupment must comply with applicable state wage payment statutes: a draw is not an advance against wages unless it is designated as such in a written agreement, and in some states, a draw that is paid and then subtracted from future earnings may be treated as an illegal wage deduction rather than a permissible recoupment of an advance. The agreement should specify clearly that the draw is an advance against earned commissions, that recoupment will occur through offset against commissions rather than through direct deduction from wages, and that the associate will not be required to repay a draw deficit if employment ends before the deficit is recovered.

Stay bonuses are a structurally distinct retention mechanism that DSOs use at acquisition to incentivize the target practice's key clinical staff to remain through a defined post-closing integration period. A stay bonus is typically structured as a lump sum payment made at the end of a defined period, conditioned on the associate's continued employment through a specified date, and it vests in full rather than on a prorated basis in most cases. From a tax perspective, the stay bonus is ordinary income to the recipient and a deductible compensation expense to the employer, and it should be distinguished in the purchase agreement from any portion of the purchase price that is allocated to the seller-owner's personal goodwill or covenant not to compete. The stay bonus period typically ranges from six to eighteen months post-closing and is calibrated to the integration timeline for the specific practice.

An acquiring DSO should model the total retention cost including stay bonuses for all clinical staff before finalizing the purchase price, because retention costs are a real transaction expense that affect returns. A practice where the existing associates are unwilling to commit to a stay bonus period at reasonable compensation terms is signaling either that the compensation offered is below market or that the associates have reservations about working for the DSO that should be investigated before closing. The seller's representations in the purchase agreement should include a statement that the seller has not received notice from any associate of an intention to resign or of a material concern about the transition to the new owner.

Non-Compete Enforceability: Geographic Scope, Duration, State-by-State Analysis

Non-compete agreements in veterinary and dental associate employment are among the most litigated provisions in the industry, and enforceability varies more by state than by what is written in the contract. An agreement that contains a two-year, ten-mile radius non-compete may be fully enforceable in Michigan or Texas, partially enforceable after judicial blue-penciling in Maryland or New Jersey, and completely void in California, North Dakota, or Oklahoma. The acquiring DSO must identify the governing law for every associate agreement it assumes, assess enforceability under that law, and determine whether the non-compete it intends to rely on for post-acquisition competitive protection actually provides the coverage it expects.

California Business and Professions Code Section 16600 renders void any contract that restrains an individual from engaging in a lawful profession, trade, or business of any kind. The Legislature's 2023 amendments eliminated the disputed "narrow restraint" exception and made clear that California's prohibition on non-competes is categorical. Courts have also applied California's prohibition to out-of-state employers who seek to enforce non-competes against California employees under choice-of-law provisions designating another state's law. North Dakota and Oklahoma have similarly categorical prohibitions. An associate agreement with a California choice-of-law provision, or one being enforced against a California-employed clinician, contains a non-compete that is functionally unenforceable.

New York's Freedom to Work Act of 2024 substantially restricts non-compete agreements for employees and explicitly prohibits non-competes for most workers who perform services for compensation. The Act's coverage of professional employees, including licensed doctors, is subject to ongoing legal analysis, but the practical effect is that non-competes for dental and veterinary associates working as employees in New York face a significantly more difficult enforcement environment than they did before the Act's passage. Massachusetts's Noncompetition Agreement Act, in effect since 2018, requires non-compete agreements to be provided to prospective employees at the time of a formal offer or ten business days before employment, to be supported by mutually agreed upon consideration beyond employment, to be reasonable in geographic scope and duration not exceeding one year, and to include either a garden leave payment or other mutually agreed consideration during the restricted period.

Illinois's Freedom to Work Act, as amended in 2021, prohibits non-compete agreements for employees earning below $75,000 per year and non-solicitation agreements for employees earning below $45,000 per year. Illinois also requires that the employer advise the employee in writing to consult an attorney before signing, provide the agreement at least 14 days before employment begins, and ensure the agreement is supported by adequate consideration beyond employment itself. For dental and veterinary associates in Illinois who fall below the income threshold, non-competes are unenforceable regardless of what the signed agreement says. Geographic scope analysis in states that do enforce non-competes typically examines the radius in relation to the practice's actual patient draw area, with courts in urban markets applying skepticism to radii exceeding five to seven miles and courts in rural markets accepting broader geographic restrictions that reflect longer patient travel distances.

Non-Solicitation of Patients and Referral Sources, Customer List Ownership Post-Employment

Non-solicitation provisions are legally distinct from non-compete provisions, and states that prohibit non-competes often apply a different and more permissive standard to non-solicitation of patients and referral sources. A non-solicitation clause that prohibits the departing associate from contacting former patients to invite them to follow to a new practice, or from reaching out to specialist referral sources the associate cultivated during employment, restricts a narrower category of conduct than a geographic non-compete and is more likely to be enforced even in states with strong employee protections.

Patient ownership in veterinary and dental practices involves a tension between the practice's proprietary interest in its client list and the patient's independent right to choose their healthcare provider. The American Dental Association's Code of Professional Responsibility and the American Veterinary Medical Association's Principles of Veterinary Medical Ethics both address the patient's right to choose, but neither professional code preempts the contractual obligation a licensed professional may owe to a former employer regarding active solicitation of that employer's clients. A non-solicitation clause that prohibits active solicitation of former patients is generally enforceable; a clause that purports to prevent a departing clinician from accepting former patients who contact the clinician of their own volition is more vulnerable to challenge because it arguably infringes on the patient's right to choose their provider.

Customer list protection in a DSO acquisition raises the question of what records the departing associate may retain or use. A practice's patient database, including appointment histories, treatment records, and contact information, is the practice's proprietary information and is covered by both the employment agreement's confidentiality provisions and applicable health privacy regulations. The HIPAA Privacy Rule governs the use and disclosure of protected health information and applies to dental practices as covered entities. Veterinary practices are generally not covered entities under HIPAA, but state veterinary practice acts and the employment agreement's confidentiality provisions still protect patient information from unauthorized use. A departing associate who uses the practice's patient list to send solicitations to former patients has likely violated both the employment agreement and applicable professional regulations, even in a state that prohibits non-competes.

Referral source non-solicitation is a distinct category that protects the practice's relationships with referring specialists, general practitioners, and other professional contacts who direct patients to the practice. In veterinary medicine, the referral relationship between general practitioners and specialty referral centers is commercially significant and is frequently addressed in employment agreements for associate specialists. A departing specialist who contacts the referring practitioners with whom they cultivated relationships during employment and invites those practitioners to redirect referrals to the specialist's new practice is engaging in conduct that falls squarely within the scope of a referral source non-solicitation provision, even if the specialist is not technically competing geographically with the former employer.

Loan Repayment Assistance, Public Service Loan Forgiveness Preservation, and Employer PSLF Certification

Student loan debt burden is among the most significant financial considerations for newly licensed veterinarians and dentists, and the structure of employer loan repayment assistance in an employment agreement has material value that candidates weigh alongside base compensation and production bonuses. Employer loan repayment assistance programs are structured in several ways: as direct monthly payments to the servicer that supplement the associate's own payments, as lump sum annual bonuses designated for loan repayment, or as employer-side financing arrangements that pay down principal at defined milestones. The tax treatment of these payments depends on the structure: employer contributions to loan repayment that qualify under the Educational Assistance provisions of IRC Section 127 are excludable from the employee's income up to the annual limit, while payments structured as compensation bonuses are fully taxable.

Public Service Loan Forgiveness is a federal program that forgives the remaining balance on Direct Loans after 120 qualifying monthly payments made under an income-driven repayment plan while employed full-time by a qualifying employer. A qualifying employer is a government entity or a 501(c)(3) nonprofit organization. The PSLF program has particular relevance in the veterinary and dental context because many of the practitioners who enter these fields carry substantial educational debt and some initially practice at nonprofit health centers, community health organizations, or government veterinary services that qualify under the program before transitioning to private practice or DSO employment.

A DSO acquisition that converts an associate's employer from a qualifying nonprofit to a for-profit corporate entity disrupts the associate's PSLF eligibility from the date of the employer change. Payments made after the associate begins working for a for-profit DSO do not count toward the 120-payment threshold regardless of whether the associate's work is clinically identical to their pre-acquisition work. This disruption is a meaningful economic harm for an associate who is close to reaching the 120-payment threshold and whose remaining loan balance is substantial. Identifying this issue in diligence, quantifying the financial impact for affected associates, and designing a transition structure that preserves qualifying employment status where possible, are services that associate-side counsel should provide and that acquirer-side counsel should anticipate.

Employer PSLF certification is an annual process through which the qualifying employer signs a form confirming the employee's full-time qualifying employment during the relevant period. When an employer of record changes due to an acquisition, the new employer can only certify qualifying employment for periods during which it was the employer of record. The predecessor entity, if it was a qualifying employer, must complete certification for the pre-acquisition period before the transaction closes or must cooperate post-closing in completing retroactive certifications. The purchase agreement should include a covenant from the seller to cooperate in completing PSLF employer certifications for affected associates covering all periods of qualifying employment with the predecessor, and a specific timeframe within which the seller will complete and return certification forms requested by affected associates after closing.

Malpractice Insurance Coverage: Claims-Made Tail, Nose Coverage, and Prior Acts Coverage

Professional liability insurance for veterinarians and dentists is structured primarily on a claims-made basis, meaning the policy covers claims made and reported during the policy period rather than covering incidents that occurred during the policy period regardless of when the claim is made. This structure creates a coverage gap when an associate transitions from one employer to another, or when an employer changes its insurance carrier: claims arising from services rendered during the prior policy period that are not made until after the policy expires are not covered under the expired claims-made policy. Addressing this gap requires either tail coverage or nose coverage, and the employment agreement must specify which approach applies and who bears the cost.

Tail coverage, also known as an extended reporting endorsement, is purchased at the end of the claims-made policy period and extends the reporting window for claims arising from services rendered during the policy period. Tail premiums are typically significant, often equivalent to 200 to 300 percent of the annual policy premium, because they cover an unlimited future window for reporting claims from a defined historical period. The cost allocation question in an associate employment agreement is whether the employer or the departing associate pays the tail premium. Employers frequently draft agreements requiring the departing associate to pay for tail coverage regardless of the reason for termination, which places the full cost on the associate even when the employer initiates the separation or when the separation occurs because the practice was sold to a new owner.

Nose coverage, also known as prior acts coverage, is purchased by an incoming insurer and extends coverage backward to cover claims arising from services rendered before the new policy's inception date. A DSO that acquires a practice and maintains its own professional liability program may purchase nose coverage for acquired clinicians as part of its insurance transition, eliminating the need for individual associates to purchase tail coverage for the prior period. This approach is more administratively efficient and typically less expensive at scale than requiring each individual associate to purchase their own tail coverage. The employment agreement should specify whether nose coverage will be provided for prior acts, identify the coverage limits that will apply, and confirm that the nose coverage will apply to claims arising from the associate's pre-acquisition clinical work at the target practice.

Prior acts coverage analysis in the diligence process should review any claims or potential claims that the target practice's associates are aware of at the time of acquisition. A claim that has been submitted or threatened but not reported to the prior carrier may fall into a gap between the prior claims-made policy and the new coverage if the reporting deadline of the prior policy has passed. The representations and warranties in the purchase agreement should require the seller to disclose all known or threatened malpractice claims, all incidents that the seller believes could give rise to a claim, and the current status of any pending claims and the applicable coverage. An undisclosed claim that surfaces after closing may not be covered by any available policy if the prior claims-made policy has expired and the nose coverage was not designed to capture it.

Credentialing and Privileging: Medicare Enrollment, Commercial Payer Credentialing, and NPI Types

Provider credentialing is the administrative process through which a health plan or Medicare verifies that a licensed professional meets the qualifications required to participate in the network and bill for services. For dental and veterinary practices, credentialing affects which payers the associate can bill under their own National Provider Identifier number, how long the credentialing process takes when a new employer or ownership change triggers re-credentialing, and whether there is a gap in billing capability during the transition that interrupts revenue flow. In a DSO acquisition, every associate's credentialing status must be reviewed to confirm that re-credentialing requirements are identified and initiated before closing.

The National Provider Identifier system assigns two types of identifiers. Type 1 NPIs are assigned to individual practitioners and follow the individual regardless of employer changes. Type 2 NPIs are assigned to organizations and are associated with the specific legal entity that holds the enrollment. When a practice acquisition results in a change of the billing entity, from the selling practice entity to the DSO or its management services affiliate, the Type 2 NPI changes and all payer enrollments tied to the practice's Type 2 NPI must be updated. Commercial payers require submission of a new participation agreement or an amendment reflecting the change of billing entity, and the processing time for these updates varies from two weeks to several months depending on the payer. During the processing period, claims submitted under the new Type 2 NPI may be delayed or denied, which creates an accounts receivable gap that must be accounted for in the transaction's working capital analysis.

Medicare dental coverage is limited, and most dental practices do not bill Medicare for routine dental services. However, dentists who treat oral surgical conditions, perform maxillofacial procedures covered under the medical benefit, or work in federally qualified health centers may have Medicare enrollments that are affected by a change of ownership. Medicare's change of ownership rules require the acquiring entity to either accept assignment of the existing Medicare provider agreement, which includes acceptance of any outstanding Medicare overpayments or compliance obligations, or to enroll as a new provider. Accepting assignment of the provider agreement binds the acquirer to pre-closing compliance obligations and is generally disfavored unless the practice's Medicare compliance history has been reviewed thoroughly in diligence.

Veterinary practices generally do not participate in Medicare or Medicaid, but they may have credentialing relationships with pet insurance carriers, corporate wellness program providers, and state agricultural or animal health programs that are affected by an ownership change. The scope of these relationships should be documented in diligence and the assignment or re-credentialing requirements for each should be identified. A veterinary specialty referral center that participates in a carrier-specific specialty credentialing program may face re-credentialing requirements triggered by a change of ownership or a change in the specialist's employment status that are not immediately obvious from reviewing the participation agreement. Specialty credentialing gaps can interrupt the referral pipeline from general practitioners who rely on the specialist's network participation as a billing condition for their referring clients.

Clinical Autonomy and Treatment Protocols: DSO Intrusion Risks and Scope of Practice Restrictions

The corporate practice of medicine doctrine, and its equivalents under state dental and veterinary practice acts, prohibits lay corporations from employing licensed professionals to practice their licensed profession where the corporate entity exercises control over clinical judgment. The doctrine is intended to ensure that clinical decisions are made by licensed professionals acting in the best interest of the patient rather than by corporate officers acting in the interest of shareholder returns. DSOs and veterinary management companies operate within the boundaries of this doctrine through management services organization structures that separate the clinical practice entity from the management company, with the clinical entity remaining under the ownership of a licensed professional.

Despite this structural separation, DSO employment agreements frequently include provisions that constrain the clinical autonomy of associate doctors in ways that raise corporate practice concerns. Required treatment plan templates, mandatory use of specific materials or laboratory providers, minimum production targets that incentivize over-treatment, and quality assurance processes that allow non-clinical managers to override clinician treatment decisions are the most common mechanisms through which corporate interests influence clinical judgment. The associate's employment agreement should be reviewed for provisions that require compliance with clinical protocols developed by non-clinical management, that make continued employment conditional on meeting production thresholds, or that give the DSO authority to direct which procedures an associate may or may not perform.

Scope of practice restrictions are a related but distinct concern. State licensing boards define the scope of practice for each licensed profession, and an employment agreement cannot restrict an associate's practice to procedures below the authorized scope without the associate's informed consent to that limitation. Some DSO agreements limit associates to performing only the procedures that the DSO's operational infrastructure is designed to support, which may be a narrower range of procedures than the associate is licensed to perform. An associate who agrees to a scope of practice restriction in an employment agreement and then performs services outside that restriction may face both contract claims from the employer and potential licensing issues if the restriction was tied to a credentialing or supervision requirement.

Negotiating clinical autonomy protections in an employment agreement requires affirmative drafting rather than reliance on state law defaults. The agreement should include a provision that the employer will not require the associate to perform, recommend, or withhold treatment in a manner that conflicts with the associate's professional judgment or applicable licensing standards. The agreement should specify that disagreements about treatment protocols will be resolved through a defined process that includes clinical input rather than unilateral management decision. A provision that makes clear the associate's professional license obligations take precedence over corporate directives in matters of clinical judgment is both legally supportable under the corporate practice doctrine and practically important as a reference point in any future dispute.

Equity Participation: Practice Buy-In Programs, Partnership Track, and DSO Equity Pools

Equity participation is one of the primary tools DSOs and multi-site veterinary groups use to recruit and retain senior associates and to align clinical leadership with the platform's long-term objectives. Equity structures in this context take several forms: practice-level buy-in programs that allow an associate to purchase a minority ownership stake in a specific practice entity; partnership track programs that provide a defined pathway to equity participation in the local practice or the broader platform; and DSO equity pool participation that grants units in a parent entity rather than ownership in any specific practice location.

Practice-level buy-in programs typically involve the associate purchasing a defined percentage of the clinical practice entity at a formula price based on a multiple of EBITDA or a defined book value. The buy-in price may be financed by the employer through a promissory note, paid in cash, or structured as a compensation offset over time. The associate's rights as a minority owner are defined by the operating agreement of the practice entity, and minority ownership in a DSO-affiliated practice may provide fewer governance rights than minority ownership in an independent practice because the management services agreement between the clinical entity and the DSO management company typically constrains the clinical entity's operational discretion. An associate considering a practice buy-in should review the management services agreement carefully to understand what the clinical entity actually controls and what decisions are reserved to the DSO.

DSO equity pool participation grants the associate an interest in a broader enterprise rather than a specific practice, and the value of that interest depends on a future liquidity event such as a sale of the DSO platform, a recapitalization, or an initial public offering. The timeline and terms of such liquidity events are uncertain at the time the associate receives the equity grant, and the associate's ability to assess the value of the grant depends on information about the platform's capitalization structure, outstanding debt, senior equity classes, and projected growth that the DSO may not be willing to disclose fully. An associate who accepts DSO equity as a material component of compensation is making an investment decision as well as an employment decision, and should seek disclosure of the information necessary to assess the equity's likely value before committing to compensation terms that include equity as a meaningful offset to cash pay.

Partnership track timelines in employment agreements are frequently drafted in aspirational rather than contractual terms, creating an expectation without a legally enforceable obligation. A well-negotiated partnership track provision specifies the criteria for eligibility, the timeline within which an offer will be made after the criteria are satisfied, the valuation method for the equity interest available for purchase, and the remedy available to the associate if the employer fails to make a timely offer following satisfaction of the criteria. Without these specific terms, a partnership track provision is a retention tool that may create moral but not legal obligation, and an associate who relies on it may find that the pathway does not materialize on the schedule or at the economics they anticipated.

Termination for Cause: Professional Misconduct, Board Complaints, and Automatic Termination Triggers

Termination for cause provisions in associate employment agreements perform two functions: they define the circumstances under which the employer may terminate without the notice period or severance obligations that apply to terminations without cause, and they identify the events that give either party the right to immediate termination. Cause definitions that are overly broad or that include subjective criteria give employers discretion to characterize a wide range of employment decisions as for-cause terminations and thereby avoid the financial consequences of a without-cause separation. Cause definitions that are narrowly drafted provide associate protection at the cost of making it more difficult for the employer to address genuine performance or professional conduct problems efficiently.

Professional misconduct events that universally constitute cause in well-drafted agreements include felony conviction or a guilty plea to a felony, fraud against patients or payers, confirmed substance impairment in a clinical setting, sexual misconduct involving a patient or subordinate staff member, and material misrepresentation on the associate's employment application regarding credentials or prior disciplinary history. These categories are broadly accepted as appropriate cause triggers because they represent conduct that is incompatible with continued clinical practice regardless of the details of any individual incident. The automatic termination trigger most important to specify clearly is loss of state professional license: the agreement should specify that termination occurs upon the loss of licensure rather than upon the initiation of a board proceeding, because initiating a proceeding is a common event that does not necessarily predict the outcome.

Board complaint handling presents a particular challenge in the termination for cause framework. State licensing boards investigate complaints from patients, former employees, and other practitioners, and an investigation does not constitute a finding of misconduct. An employment agreement that treats the filing of a board complaint, or even the initiation of a formal investigation, as an automatic cause event places the associate in an immediately precarious employment position based on an allegation that may be unsubstantiated. A more protective provision for the associate specifies that a board complaint does not constitute cause unless and until a final board order has been issued finding that the associate violated applicable professional standards, and provides the associate with notice and the right to respond before any suspension of clinical duties during the proceeding.

DEA registration loss is an automatic cause event in both veterinary and dental agreements and requires no cure period because the ability to prescribe controlled substances is integral to clinical practice in both professions. Loss of DEA registration may result from a voluntary surrender, an administrative proceeding, or a criminal conviction, and each pathway has different implications for the associate's ability to regain registration and continue practicing. The employment agreement should address what happens to the associate's employment status during a suspension of DEA privileges that is anticipated to be temporary, distinguishing between a temporary administrative hold pending investigation and a final order revoking registration, and specifying the conditions under which the employer will or will not maintain the employment relationship during a defined reinstatement period.

Severance, Garden Leave, Benefits Continuation, COBRA, and State Board Notification

Severance obligations in associate employment agreements are almost entirely a matter of contract rather than statutory requirement. No federal statute mandates severance pay for at-will or term employees outside of specific plant-closing contexts covered by WARN. State laws in most jurisdictions similarly do not require severance. The employment agreement's severance provision, if any, defines the employer's obligation upon a without-cause termination, and the absence of any severance provision means the employer has no obligation to pay beyond the final paycheck and any accrued PTO required by state law. For a mid-level to senior associate, negotiating a severance formula based on tenure is a reasonable ask that provides meaningful protection against the financial disruption of an involuntary separation.

Garden leave provisions allow the employer to place the associate on paid leave during a notice period rather than requiring the associate to continue working. This is advantageous for the employer in situations where the associate is departing to join a competitor, because it allows the employer to remove the associate from patient contact and clinical systems while still triggering the notice period that delays when the associate can begin competing. For the associate, garden leave is preferable to a notice period with continued active employment if the relationship has deteriorated, because it provides income continuity without the awkwardness of continued presence at a workplace where the transition has been announced. Garden leave provisions should specify that the associate's employment status, and therefore their benefit plan eligibility, continues through the garden leave period and that the garden leave pay does not reduce any severance obligation payable at the end of the leave period.

COBRA continuation rights for dental and veterinary associates have particular complexity when the employer's health plan includes specialty coverages such as mental health and substance use treatment, dental coverage, and ancillary benefits that the associate relies on. As noted elsewhere in this analysis, COBRA covers group health plans maintained by employers with 20 or more employees, and state mini-COBRA laws extend similar rights in some states for smaller employers. The COBRA election window is 60 days from the later of the qualifying event or the date the qualifying event notice is provided, and the associate must be informed of this window and the applicable premium amount promptly to preserve their ability to make an informed election.

State board notification obligations arise in several contexts at the end of an associate's employment. Some states require the employing practice to notify the licensing board when a licensed professional's employment is terminated for cause involving professional misconduct, substance abuse, or patient safety concerns. These mandatory reporting obligations exist independently of the employment agreement and cannot be waived by contract. The employment agreement should address how mandatory reporting will be handled, specify whether the associate will be provided an opportunity to review the form and content of any report before it is submitted, and confirm that reports will be limited to what is required by law rather than used as a punitive mechanism for disputed employment separations. An employer who files a board report in connection with a termination that is actually a commercial dispute rather than a genuine professional misconduct event exposes itself to claims for tortious interference and defamation that are not covered by professional liability insurance. Alex Lubyansky and the Acquisition Stars team provide legal counsel to platforms and associates navigating these employment issues in veterinary and dental M&A. Reach us at 248-266-2790.

Frequently Asked Questions

Related Resources

Associate doctor employment agreements are not boilerplate documents that can be addressed uniformly across a DSO platform's portfolio. They govern relationships with the licensed professionals who generate the revenue the acquirer purchased, and their terms carry legal consequences that range from non-compete enforcement disputes to malpractice coverage gaps to PSLF disruption for individual clinicians. Each category of issue requires legal analysis at the transaction stage where the terms can still be negotiated, not during the integration period when the employment relationships have already been established on whatever terms were in the documents at closing.

Acquisition Stars represents buyers, sellers, and associate clinicians in veterinary and dental practice transactions with the legal precision these employment issues require. From classification analysis and compensation structure review to non-compete enforceability assessment and malpractice coverage coordination, the firm provides transaction counsel that addresses the employment layer of a practice acquisition with the same rigor applied to the purchase price mechanics. Contact us at 248-266-2790 or through the form below to discuss the associate employment aspects of your transaction.